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Abstract
The incidence of autism spectrum disorders, a heterogenous group of neurodevelopmental disorders is increasing. In response, 
there has been a concerted effort by researchers to identify environmental risk factors that explain the epidemiological changes 
seen with autism. Advanced parental age, maternal migrant status, maternal gestational stress, pregnancy and birth complications, 
maternal obesity and gestational diabetes, maternal vitamin D deficiency, use of antidepressants during gestation and exposure 
to organochlorine pesticides during pregnancy are all associated with an increased risk of autism. Folic acid use prior to pregnancy 
may reduce the risk of autism. Exposure to antenatal ultrasonography, maternal gestational cigarette and alcohol use do not 
appear to influence the risk of autism in offspring. There is little evidence that exposure to environmental toxins such as thimerosal, 
polybrominated diphenyl ethers and di-(2-ethylhexyl) phthalate in early childhood increases the risk of autism. Apart from birth 
complications, the current evidence suggests that the majority of environmental factors increasing the risk of autism occur in the 
antenatal period.  consistent with the rise in incidence in autism, some of these environmental factors are now more common in 
developed nations. Further research is required to determine how these environmental exposures translate to an increased risk of 
autism. Understanding how these exposures alter neurodevelopment in autistic children may inform both the aetiopathogenesis and 
the strategies for prevention of autism. 
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Background
Autism spectrum disorders (ASD) are a heterogenous group 
of neurodevelopmental disorders affecting approximately one 
percent of children.1,2 The characteristic triad of impairments 
in communication, social difficulties and restricted interest or 
repetitive behaviours, together with difficulties in emotional 
processing, sensory-perceptual processing, and motor proficiency, 
adversely affect developmental trajectories and family functioning 
from the early years.3 Impact routinely continues across the 
lifespan adversely affecting independence, education, and 
participation in school, work, and community life.4 Although 
early intervention can benefit some children with autism,5 the 
ongoing disability experienced by many individuals is severe. The 
neurodevelopmental changes responsible for ASD arise from a 
combination of  genetic, epigenetic and environmental factors.6,7
Of great concern, the incidence of autism is increasing. Whilst 
a proportion of the increase is  attributable to the broadening of 
diagnostic boundaries and improved identification of ASD cases,8 
it is widely viewed that there is also a true increase in the incidence 
and prevalence of autism.2 For example in California, cases of 
autism diagnosed by developmental services rose from 6.2/10000 
births in 1990 to 42.5/10000 births in 2001. Broadening of 
diagnostic criteria and earlier age of diagnosis accounted for almost 
70% of the increase in incidence, however almost one third of the 
increase in incidence of ASD was unexplained by these factors.9 
This changing epidemiology has resulted in a concerted research 
effort to identify non-genetic (environmental) factors that explain 
the increase in incidence of ASD. Identification of environmental 
risk factors will provide opportunities to both better understand 
the aetiopathogenesis of ASD and to implement strategies that 
lead to prevention of the disorder.  
Parental risk factors for autism prior to pregnancy
Parental migration and advanced parental age are both associated 
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with an increased risk of having offspring with ASD. A systematic 
review by Dealberto (2011)10 reported an increase in relative risk 
(RR) of autism in the offspring whose mothers were of foreign 
birth.  The relative risks varied depending on ethnicity, with 
offspring of dark skinned migrants at particularly high risk of 
autism. An earlier meta-analysis by Gardener and colleagues11 also 
reported an increased risk of autism for children who had mothers 
born abroad. In an English case control study of 428 children with 
autism, mothers born in the Caribbean region had approximately 
a 10 fold risk of having a child with ASD compared to English 
born white mothers.12 In a large Swedish case control study, 
mothers who had immigrated around the time of pregnancy had 
the greatest increased risk of having a child with autism.13 
It has been suggested that the increase in risk of autism in 
the offspring mothers who are of dark skinned ethnicity and 
have migrated to Northern European countries supports the 
hypothesis that maternal vitamin D deficiency is the mediating 
factor.14 Vitamin D deficiency is an attractive candidate risk factor 
for autism.15 It has been shown to have a key role in foetal brain 
development16 and the incidence of autism has been shown to 
increase with an increase in latitude, where vitamin D deficiency 
is most likely to occur due to reduced exposure to sunlight.17 
However, the migration studies suggest that the act of migration 
was an important independent risk factor for offspring with 
autism.12,13 Maternal stress during pregnancy has also been shown 
to be associated with an increased risk of autism18 and it is a 
plausible mediating factor for the association between migrant 
mother and ASD.  
Advanced parental age is another risk factor where there is 
robust evidence from two meta-analyses finding a significant 
association with an increased risk of autism in the offspring. 
Comparing mothers who were greater than 35 years of age with 
mothers aged between 25 to 29 years, the relative risk (RR) for 
autism in the offspring after adjusting for paternal age was 1.31 
(95% Confidence Interval (CI) =1.19-1.45).19 In a meta-analysis 
of paternal age and risk of autism, Hultman and colleagues 
(2011) reported that compared to fathers aged < 29 years, the 
RR for autism in offspring were 1.22 in fathers aged 30-39 years 
(CI=1.05-1.42), 1.78 in fathers aged 40-49 years (CI=1.52-2.07) 
and 2.46 for fathers aged 50 and older (CI=2.20-2.76).20  
The association between advanced maternal age and increased 
risk of autism in offspring may be explained by the increased 
likelihood of maternal gestational obesity and diabetes21 and 
increased risk of antenatal or perinatal complications in older 
mothers.11,22  Increased likelihood of genetic mutations might 
explain the increased risk of ASD in older fathers. Spermatogonia 
undergo cell division every sixteen days, resulting in approximately 
200 divisions by the age of 20 years and 660 divisions by the age 
of 40 years.23 Each time the cell divides, the replication of the 
genome introduces the possibility of copy error mutations, such 
as point mutations, or larger copy number variants (e.g. deletions, 
amplifications). Animal experimental studies have recently 
confirmed that the offspring of older males have an increased 
risk of de novo copy number variants,24 and these regions contain 
genes implicated in both schizophrenia and autism. Apart from 
mutations that change the DNA sequence, epigenetic mechanisms 
may also be involved.25
Risk factors for autism identified in pregnancy.  
In a meta-analysis of 40 studies of pregnancy complications which 
included cohorts with a total of 1086271 participants, maternal 
gestational diabetes was associated with a two-fold risk of autism, 
maternal medication use during pregnancy was associated with 
a 46% increased risk of autism and psychiatric medication use 
during pregnancy was significantly positively associated with 
Autism (RR=1.68). In the Childhood Autism Risks from Genetics 
and the Environment (CHARGE) study, children with autism 
whose mothers had diabetes during pregnancy had lower scores 
of expressive language compared to children with autism whose 
mothers had no metabolic conditions.21 Evidence is emerging 
that maternal metabolic conditions have a broad adverse 
impact on offspring neurodevelopment. Compared to normal 
gestational weight, obesity in pregnancy is associated with delayed 
cognitive development in offspring.26 At this time, the biological 
mechanisms underpinning the association between maternal 
obesity in pregnancy and offspring neurodevelopmental delays are 
unclear. 
Maternal stress during pregnancy has long been proposed 
as a risk factor for autism.27 In the most convincing natural 
experiment, the prevalence of autism in the offspring of 
mothers exposed to severe weather events in Louisiana was 
13.32/10000 compared to a much lower prevalence of  4.49/ 
10000 in controls.18 Increased cortisol levels in the amniotic 
fluid and decreased placental blood flow are two mechanisms 
proposed to explain how stress may alter neurodevelopment.28 
Since the introduction of selective serotonin reuptake inhibitors 
(SSRIs), there has been widespread use of antidepressants 
in developed countries. In a case control study of gestational 
use of antidepressant medication and risk of autism, 6.7% of 
mothers of children with autism used SSRIs compared to 3.3% 
of mothers of typically developing children. After adjusting for 
markers of mental health such as diagnosis and health service 
usage, use of SSRIs during pregnancy remained significantly 
associated with risk of autism.29 The effect of antidepressant 
and other medications commonly taken in pregnancy on 
neurodevelopment requires further research. 
Gestational exposure to toxins in the environment have been 
identified as increasing the risk of autism in offspring. Living in 
close proximity to a freeway was associated with a twofold increase 
in risk of autism (Odds Ratio and 95% CI 1.86; 1.04-3.45) 
presumably as a result of air pollution.30 Gestational exposure to 
organochlorine pesticides, specifically endosulfan and dicofol, 
have been associated with a six-fold increased risk of autism in 
the offspring.31 In spite of the strong association, it is unlikely 
that organochlorines are responsible for the increase in incidence 
of autism in developed countries. The use of these pesticides has 
become highly regulated and in many countries they are banned 
altogether.       
Some environmental exposures in pregnancy have been shown 
to have no association with increased risk of autism. Reassuringly, 
the use of ultrasound in pregnancy is not associated with increased 
risk of ASD.32 Although gestational alcohol and cigarette use is 
associated with a broad range of adverse health outcomes in the 
offspring, no association was found between these exposures and 
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increased risk of autism.33,34 Finally, Beard and colleagues (2011) 
proposed that excess maternal folic acid use to prevent neural tube 
defects might account for the increase in incidence of autism.35 
This hypothesis has not been supported by the available evidence. 
In fact, a report from the CHARGE study found that the risk of 
autism decreased in mothers who had taken folic acid and vitamins 
in the three months prior to pregnancy and the first month of 
pregnancy.36 The authors suggested that peri conception vitamin 
and folic acid use may reduce the risk of autism in offspring. 
Perinatal and neonatal complications and risk of 
autism
In a recent meta-analysis, Gardener and colleagues examined more 
than 60 perinatal and neonatal factors and autism risk. Perinatal 
factors associated with the autism risk included  abnormal foetal 
presentation, umbilical-cord complications, birth injury or trauma, 
maternal hemorrhage, low birth weight, small for gestational 
age, low 5-minute Apgar score, meconium aspiration, neonatal 
anemia, ABO or Rh incompatibility, and hyperbilirubinemia.22 
Premature birth is also a risk factor for altered neurodevelopmental 
trajectories including autism.37 As there have been significant 
advances in obstetric care, it is counter-intuitive to consider that 
an increase in autism incidence might be explained by perinatal 
complications. However, improved obstetric care has resulted in 
the live births of babies that previously may not have survived. In 
light of this, perinatal complications may play a role in increasing 
the incidence of autism.38    
Risk factors operating in early childhood
Compared to environmental risk factors for autism that have 
been identified prior to and during pregnancy, the evidence for 
risk factors in early childhood is less convincing. Multiple studies 
of exposure to thimerosal, a mercury containing preservative that 
was used in vaccines had reported no increased risk of ASD in 
children from American samples.39,40 This finding has also been 
found in studies consisting of European41,42 and Japanese cohorts.43 
Consistent with this finding, the CHARGE study reported no 
difference in the total blood mercury concentrations of children 
with ASD and controls.9 Polybrominated diphenyl ethers 
(PBDEs) are flame retardants that are widely used in developed 
countries and have been shown to affect neurodevelopment in 
animal models. The CHARGE study examined this exposure and 
found that PBDE levels were high in both children with ASD and 
typically developing children and there was no difference in levels 
between the two groups.9
In a case-control study of 48 children with ASD and 45 
matched controls, primary and secondary metabolites of di-(2-
ethylhexyl) phthalate (DEHP) was found to be higher in children 
with autism.44 Phthalates are used as plasticizers, solvents and 
additives in many consumer products such as vinyl flooring, 
wall coverings and food containers.45 Testa and colleagues (2012) 
proposed that through endocrine disruption, phthalates may 
play a role in altering neurodevelopment of neurotransmitter 
systems.44 A prospective study showed that children aged 4-9 
years with higher prenatal phthalate exposure performed poorer 
on tests of executive functioning and externalising behaviours 
with increased risk of problems such as aggression, attentional 
weaknesses and conduct problems however autism was not an 
outcome of this study.46 Phthalates need to be investigated in a 
larger study to determine the role if any that they might have in 
the aetiopathogenisis of autism. 
Toxins produced by Clostridia and Desulfovibrio bacteria in the 
gut have also been proposed as candidate risk factors for regressive 
autism.47,48 It has been hypothesised that use of antibiotics has 
lead to an alteration in the bowel flora of some children where 
there has been an overgrowth of Clostridia and Desulfovibrio 
bacteria which are resistant to penicillin and cephalosporins. 
Examination of the bacteria in the stools of children with ASD 
compared to controls showed differences in the bowel flora of the 
two groups.49,50 Further research is necessary to show evidence 
supporting these hypotheses. 
Discussion
Autism, a persistent and frequently severely disabling 
neurodevelopmental disorder, is rising in incidence. Concurrent 
with the change in the epidemiology of autism, there have been 
societal changes, particularly in developed countries that have 
increased the likelihood of exposure to some of the identified 
environmental risk factors. The risk factors for which the most 
evidence exists are shown in Table 1. 
Parental migration, advanced parental age, maternal stress, 
gestational antidepressant use and gestational metabolic 
conditions have all been shown to be associated with an increased 
risk of autism in offspring. These factors have increased in the 
population with recent changes that have occurred in developed 
nations. With the exception of air pollution and organochlorine 
pesticides, there is limited or no evidence for external toxins being 
associated with increased risk of autism. 
Autism is just one of a number of serious adverse health 
conditions that has risen in prevalence in developed countries. 
Like autism, obesity, cardiac disease and diabetes mellitus have 
also substantially increased in many countries around the world. 
It is plausible that the rise in all of these health problems is in 
part attributable to common mechanisms such as immune 
dysregulation interacting with lifestyle factors. A common 
challenge to combating the rising prevalence of these chronic 
disorders is modifying the risk factors so as to reduce their 
incidence and their associated burden of disease.   
Research is now needed to determine why exposure to 
environmental factors results in the autism phenotype in 
some children and not others. It is clear that immune system 
regulation and oxidative stress in children with autism is 
different to that of typically developing children.51-53 However, 
the epidemiology suggests that the main environmental risks 
for autism occur prior to or during pregnancy. Understanding 
how these exposures alter neurodevelopment in autistic children 
may inform both the aetiopathogenesis and the strategies for 
prevention. 
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